NVO Reports New Positive Phase III Data on Mim8 in Hemophilia A
23/6 17:25
Novo Nordisk's Mim8 shows strong safety and patient preference in the phase IIIb hemophilia A study switching from Hemlibra to Mim8....
|
|
|
23/6 17:25
Novo Nordisk's Mim8 shows strong safety and patient preference in the phase IIIb hemophilia A study switching from Hemlibra to Mim8....